Window Therapeutics, Inc. — Form D
Window Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-13. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-13
- Form: D
- Accession: 0001997408-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Minimum investment: $50K
- Investors: 10
- Date of first sale: 2023-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-494640
Issuer
- Name: Window Therapeutics, Inc.
- CIK: 0001997408
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: VENTURE DEVELOPMENT CENTER, BOSTON, MA, 02125-3393
- Phone: (617) 287-5791
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kenneth Anderson | Director | Wellesley, MA |
| Chih-Kao Hu | Director | Boston, MA |
| Jeremiah Johnson | Director | Boston, MA |
| James Lu | Director | Shanghai, F4 |
| LUSONG LUO | Director | PITTSBURGH, PA |
| Chih-Kao Hu | Executive Officer | Boston, MA |
More